Search research articles
Contact Us
Filters
Showing results (101-110 of 215) with videos related to
Page
of 22
Sort By:
Expert Review of Anti-Infective Therapy
|
March 4, 2009
Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update
Winter J Smith, Richard H Drew, John R Perfect
International Journal of Clinical Pharmacy
|
February 1, 2015
Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection
V Paul DiMondi, Mary L Townsend, Richard H Drew
Australasian Radiology
|
November 1, 1989
Non-immune hydrops fetalis: rapidity of onset and usefulness of prenatal ultrasonography
J H Drew, C S Woodward, C A Barbaro
Expert Review of Anti-Infective Therapy
|
May 28, 2005
Liposomal amphotericin B: clinical experience and perspectives
Winter J Gibbs, Richard H Drew, John R Perfect
The Medical Journal of Australia
|
September 6, 1975
Children born from pregnancies complicated by subnormal oestriol excretion--first year
J H Drew, H J Goldenberg, N A Beischer
Pharmacotherapy
|
July 1, 1996
Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristin
R E Fuller, R H Drew, J R Perfect
Drug Safety
|
September 1, 1992
Adverse drug reactions to systemic antifungals. Prevention and management
J R Perfect, M H Lindsay, R H Drew
Pharmacotherapy
|
November 18, 2000
Antifungal pharmacodynamics: review of the literature and clinical applications
E S Dodds, R H Drew, J R Perfect
North Carolina Medical Journal
|
December 5, 2000
Recent changes in vaccination guidelines. An update on vaccines and target population initiatives
E S Dodds, D B May, R H Drew
Obstetrics and Gynecology
|
February 1, 1978
Congenital malformations, abnormal glucose tolerance, and estriol excretion in pregnancy
J H Drew, D A Abell, N A Beischer
Page
of 22
Search research articles
Search
Showing results (101-110 of 215) with videos related to
Sort By:
Page
of 22
Expert Review of Anti-Infective Therapy
|
March 4, 2009
Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update
Winter J Smith, Richard H Drew, John R Perfect
International Journal of Clinical Pharmacy
|
February 1, 2015
Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection
V Paul DiMondi, Mary L Townsend, Richard H Drew
Australasian Radiology
|
November 1, 1989
Non-immune hydrops fetalis: rapidity of onset and usefulness of prenatal ultrasonography
J H Drew, C S Woodward, C A Barbaro
Expert Review of Anti-Infective Therapy
|
May 28, 2005
Liposomal amphotericin B: clinical experience and perspectives
Winter J Gibbs, Richard H Drew, John R Perfect
The Medical Journal of Australia
|
September 6, 1975
Children born from pregnancies complicated by subnormal oestriol excretion--first year
J H Drew, H J Goldenberg, N A Beischer
Pharmacotherapy
|
July 1, 1996
Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristin
R E Fuller, R H Drew, J R Perfect
Drug Safety
|
September 1, 1992
Adverse drug reactions to systemic antifungals. Prevention and management
J R Perfect, M H Lindsay, R H Drew
Pharmacotherapy
|
November 18, 2000
Antifungal pharmacodynamics: review of the literature and clinical applications
E S Dodds, R H Drew, J R Perfect
North Carolina Medical Journal
|
December 5, 2000
Recent changes in vaccination guidelines. An update on vaccines and target population initiatives
E S Dodds, D B May, R H Drew
Obstetrics and Gynecology
|
February 1, 1978
Congenital malformations, abnormal glucose tolerance, and estriol excretion in pregnancy
J H Drew, D A Abell, N A Beischer
Page
of 22